文献速递心脑血管急症重症综合管理与镇静镇痛

2005-2018年丹麦脑出血发病率趋势及其与抗血栓药物使用的关联

Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018.
PubMed 文献 · JAMA Netw Open · 2021-05-03
一句话结论丹麦2005-2018年全国登记数据显示,抗血栓药物使用与脑出血风险相关(VKA关联最强,aOR 2.76),但同期脑出血年龄标化发病率从33/10万人年降至24/10万人年。

该病例对照研究基于丹麦全国登记数据,纳入2005年1月1日至2018年12月31日首次发生自发性脑出血的16 765例患者(平均年龄72.8岁,52.3%男性),按年龄、性别和日历年与一般人群对照1:40匹配。当前使用低剂量阿司匹林(aOR 1.51)、氯吡格雷(aOR 1.65)、VKA(aOR 2.76)和DOAC(aOR 1.83)均与脑出血相关,VKA关联最强且DOAC弱于VKA。同期口服抗凝药使用率从3.8%升至11.1%(主要因DOAC从0%升至7.0%),而脑出血年龄和性别标化发病率从33/10万人年降至24/10万人年(趋势P<.001)。作者结论认为,尽管口服抗凝药使用大幅增加,脑出血发病率反而下降。

要点

  • 当前使用VKA与脑出血关联最强(病例12.0% vs 对照5.0%;aOR 2.76;95%CI 2.58-2.96)。
  • DOAC与脑出血的关联弱于VKA(病例3.0% vs 对照1.8%;aOR 1.83;95%CI 1.61-2.07)。
  • 低剂量阿司匹林(aOR 1.51;95%CI 1.44-1.59)和氯吡格雷(aOR 1.65;95%CI 1.47-1.84)也与脑出血相关。
  • 2005至2018年口服抗凝药使用率从3.8%升至11.1%(DOAC 0%→7.0%;VKA 3.8%→4.2%)。
  • 脑出血年龄和性别标化发病率从2005年33/10万人年降至2018年24/10万人年(趋势P<.001)。

适用人群与场景

  • 2005年1月1日至2018年12月31日丹麦全国登记人群中20至99岁、首次发生自发性(非创伤性)脑出血的患者。
  • 对照为按年龄、性别和日历年1:40匹配的一般人群。

研究设计与关键结果

  • 全国病例对照研究,纳入16 765例脑出血病例(平均[SD]年龄72.8[13.1]岁;8761例[52.3%]男性),其中7473例(44.6%)在脑出血发生时暴露于抗血栓药物。
  • 当前使用低剂量阿司匹林者病例占28.7%、对照占22.6%(aOR 1.51;95%CI 1.44-1.59);氯吡格雷病例占6.2%、对照占3.4%(aOR 1.65;95%CI 1.47-1.84)。
  • 当前使用VKA者病例占12.0%、对照占5.0%(aOR 2.76;95%CI 2.58-2.96),为关联最强者;DOAC病例占3.0%、对照占1.8%(aOR 1.83;95%CI 1.61-2.07),关联弱于VKA。
  • 与2005年相比,2018年一般人群对照中口服抗凝药使用率更高(3.8% vs 11.1%),主要因DOAC使用增加(DOAC 0% vs 7.0%;VKA 3.8% vs 4.2%)。
  • 抗血小板药物使用频率下降(24.7% vs 21.4%),因低剂量阿司匹林使用减少(24.3% vs 15.3%),而氯吡格雷使用增加(1.0% vs 6.8%)。
  • 脑出血年龄和性别标化发病率从2005年33/10万人年降至2018年24/10万人年(趋势P<.001)。

证据类型、等级与局限

  • 证据类型:基于丹麦全国登记数据的病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,2005至2018年丹麦抗血栓药物使用(尤其VKA)与脑出血相关,但尽管口服抗凝药使用大幅增加,脑出血发病率下降。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Spontaneous (nontraumatic) intracerebral hemorrhage (ICH) is the most severe complication of antithrombotic drug use.

OBJECTIVES: To estimate the strength of association between use of antithrombotic drugs and risk of ICH and to examine major changes in the incidence of ICH in the general population.

DESIGN, SETTING, AND PARTICIPANTS: This case-control study of patients with a first-ever ICH from January 1, 2005, to December 31, 2018, matched by age, sex, and calendar year with general population controls (1:40 ratio), assessed case and control patients 20 to 99 years of age in population-based nationwide registries in Denmark (population of 5.8 million).

EXPOSURES: Use of low-dose aspirin, clopidogrel, a vitamin K antagonist (VKA), or a direct oral anticoagulant (DOAC).

MAIN OUTCOMES AND MEASURES: Association of ICH with antithrombotic drug use, annual age- and sex-standardized incidence rate of ICH, and prevalence of treatment with antithrombotic drugs. Conditional logistic regression models estimated adjusted odds ratios (aORs) (95% CIs) for the association of antithrombotic drugs with ICH.

RESULTS: Among 16 765 cases with ICH (mean [SD] age, 72.8 [13.1] years; 8761 [52.3%] male), 7473 (44.6%) were exposed to antithrombotic medications at the time of ICH onset. The association with ICH was weakest for current use of low-dose aspirin (cases: 28.7%, controls: 22.6%; aOR, 1.51; 95% CI, 1.44-1.59) and clopidogrel (cases: 6.2%, controls: 3.4%; aOR, 1.65; 95% CI, 1.47-1.84) and strongest with current use of a VKA (cases: 12.0%, controls: 5.0%; aOR, 2.76; 95% CI, 2.58-2.96). The association with ICH was weaker for DOACs (cases: 3.0%, controls: 1.8%; aOR, 1.83; 95% CI, 1.61-2.07) than for VKAs. Compared with 2005, the prevalence of use of oral anticoagulants among general population controls in 2018 was higher (3.8% vs 11.1%), predominantly because of increased use of DOACs (DOACs: 0% vs 7.0%; VKA: 3.8% vs 4.2%). Antiplatelet drugs were used less frequently (24.7% vs 21.4%) because of decreased use of low-dose aspirin (24.3% vs 15.3%), whereas clopidogrel use increased (1.0% vs 6.8%). The age- and sex-standardized incidence rate of ICH decreased from 33 per 100 000 person-years in 2005 to 24 per 100 000 person-years in 2018 (P < .001 for trend).

CONCLUSIONS AND RELEVANCE: In Denmark from 2005 to 2018, use of antithrombotic drugs, especially VKAs, was associated with ICH. Although use of oral anticoagulation increased substantially during the study period, the incidence rate of ICH decreased.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Hald SM, Möller S, García Rodríguez LA, et al. Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018. JAMA Netw Open. 2021. PMID: 33950207. doi:10.1001/jamanetworkopen.2021.8380

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。